Pharvaris N.V. Files 6-K, References Jan 22 Press Release

TL;DR

**Pharvaris filed a 6-K, pointing to a press release issued today, so check that for actual news.**

AI Summary

On January 22, 2024, Pharvaris N.V. filed a 6-K report with the SEC, indicating they issued a press release on the same day. This filing is a routine update for foreign private issuers, confirming their ongoing compliance with U.S. securities regulations. For investors, this filing itself doesn't contain new material financial or operational news, but rather points to an external press release that would contain such information, meaning investors need to find that press release for actual news.

Why It Matters

This filing signals that Pharvaris N.V. is actively communicating with the market via a press release, which likely contains important updates for shareholders, but the filing itself is merely a procedural notification.

Risk Assessment

Risk Level: low — This 6-K filing is purely administrative, indicating compliance and referencing an external press release, thus posing no direct risk.

Analyst Insight

An investor should locate and review the press release issued on January 22, 2024, as referenced in this 6-K, to understand any actual material news from Pharvaris N.V.

Key Players & Entities

• Pharvaris N.V. (company) — the registrant filing the 6-K
• January 22, 2024 (date) — date of the report and press release
• 001-40010 (other) — Commission File Number for Pharvaris N.V.

Forward-Looking Statements

• Pharvaris N.V. will continue to file 6-K reports for material updates as a foreign private issuer. (Pharvaris N.V.) — high confidence, target: ongoing

FAQ

From the Filing

0000950170-24-005923.txt : 20240122 0000950170-24-005923.hdr.sgml : 20240122 20240122065143 ACCESSION NUMBER: 0000950170-24-005923 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 63 CONFORMED PERIOD OF REPORT: 20240122 FILED AS OF DATE: 20240122 DATE AS OF CHANGE: 20240122 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Pharvaris N.V. CENTRAL INDEX KEY: 0001830487 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: P7 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-40010 FILM NUMBER: 24547062 BUSINESS ADDRESS: STREET 1: J.H. OORTWEG 21 STREET 2: 2333 CH LEIDEN CITY: LEIDEN STATE: P7 ZIP: 00000 BUSINESS PHONE: 31 (0)71 203 6410 MAIL ADDRESS: STREET 1: J.H. OORTWEG 21 STREET 2: 2333 CH LEIDEN CITY: LEIDEN STATE: P7 ZIP: 00000 FORMER COMPANY: FORMER CONFORMED NAME: Pharvaris, B.V. DATE OF NAME CHANGE: 20201029 6-K 1 corp_presentation_2024_u.htm 6-K 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13A-16 OR 15D-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934   For the month of January 2024 Commission File Number: 001-40010 Pharvaris N.V. (Translation of registrant’s name into English) Emmy Noetherweg 2   2333 BK Leiden   The Netherlands (Address of principal executive office)   Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F ☒ Form 40-F ☐   Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐   Note: Regulation S-T Rule 101(b)(1) only permits the submission in paper of a Form 6-K if submitted solely to provide an attached annual report to security holders.   Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐   Note: Regulation S-T Rule 101(b)(7) only permits the submission in paper of a Form 6-K if submitted to furnish a report or other document that the registrant foreign private issuer must furnish and make public under the laws of the jurisdiction in which the registrant is incorporated, domiciled or legally organized (the registrant’s “home country”), or under the rules of the home country exchange on which the registrant’s securities are traded, as long as the report or other document is not a press release, is not required to be and has not been distributed to the registrant’s security holders, and, if discussing a material event, has already been the subject of a Form 6-K submission or other Commission filing on EDGAR.   PHARVARIS N.V.   On January 22, 2024, Pharvaris N.V. (the “Company”) issued a press release. The press release is attached as Exhibit 99.1 hereto and is incorporated by reference herein. Also on January 22, 2024, the Company made available a corporate presentation on its website. A copy of the corporate presentation is attached hereto as Exhibit 99.2. Exhibit 99.1 to this Report on Form 6-K shall be deemed to be incorporated by reference into the registration statements on Form F-3 (Registration Number 333-263198 and 333-273757) and Form S-8 (Registration Number 333-252897). Exhibit 99.2 to this Report on Form 6-K shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended or the Exchange Act.             SIGNATURES   Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed